Brouard Sophie, Dupont Alexandre, Giral Magali, Louis Stéphanie, Lair David, Braudeau Cécile, Degauque Nicolas, Moizant Frédérique, Pallier Annaick, Ruiz Catherine, Guillet Marina, Laplaud David, Soulillou Jean-Paul
Institut National de la Santé Et de la Recherche Médicale, Unité 643: Immunointervention dans les Allo-et Xénotransplantations and Institut de Transplantation Et de Recherche en Transplantation, CHU Hôtel-Dieu, 44093 Nantes Cedex 01, France.
Am J Transplant. 2005 Feb;5(2):330-40. doi: 10.1111/j.1600-6143.2004.00700.x.
Most kidney transplant recipients who discontinue immunosuppression reject their graft. Nevertheless, a small number do not, suggesting that allogeneic tolerance state (referred to operational tolerance) is achievable in humans. So far, however, the rarity of such patients has limited their study. Because operational tolerance could be linked to anergy, ignorance or to an active regulatory mechanism, we analyzed the blood T-cell repertoire usage of these patients. We report on comparison of T-cell selection in drug-free operationally tolerant kidney recipients (or with minimal immunosuppression), recipients with stable graft function, chronic rejection and healthy individuals. The blood T cells of operationally tolerant patients display two major characteristics: an unexpected strongly altered T-cell receptor (TCR) Vbeta usage and high TCR transcript accumulation in selected T cells. The cytokine transcriptional patterns of sorted T cells with altered TCR usage show no accumulation of cytokine transcripts (IL10, IL2, IL13, IFN-gamma), suggesting a state of hyporesponsiveness in these patients. Identification of such a potential surrogate pattern of operational tolerance in transplant recipients under life-long immunosuppression may provide a new basis and rationale for exploration of tolerance state. However, these data obtained in a limited number of patients require further confirmation on larger series.
大多数停止免疫抑制的肾移植受者会发生移植物排斥反应。然而,少数患者并未出现排斥反应,这表明同种异体耐受状态(即所谓的临床可操作性耐受)在人类中是可以实现的。然而,到目前为止,这类患者数量稀少限制了对他们的研究。由于临床可操作性耐受可能与无反应性、忽视或一种积极的调节机制有关,我们分析了这些患者血液中的T细胞库使用情况。我们报告了无药物临床可操作性耐受的肾移植受者(或使用最小免疫抑制)、移植物功能稳定的受者、慢性排斥反应受者以及健康个体之间T细胞选择的比较情况。临床可操作性耐受患者的血液T细胞表现出两个主要特征:T细胞受体(TCR)Vβ使用情况出现意外的强烈改变,以及选定T细胞中TCR转录本高度积累。TCR使用情况改变的分选T细胞的细胞因子转录模式显示细胞因子转录本(IL10、IL2、IL13、IFN-γ)没有积累,这表明这些患者处于低反应状态。在终身免疫抑制下的移植受者中识别出这种潜在的临床可操作性耐受替代模式,可能为探索耐受状态提供新的基础和理论依据。然而,在少数患者中获得的这些数据需要在更大规模的研究中进一步证实。